|
1
|
American Cancer Society. Neuroblastoma:
What are the key statistics about neuroblastoma? http://www.cancer.org/Cancer/Neuroblastoma/DetailedGuide/neuroblastoma-key-statistics.
Accessed Dec 6, 2012
|
|
2
|
Reynolds CP and Seeger RC: Neuroblastoma.
Cancer Treatment. Haskell CM: W.B. Saunders; Philadelphia, PA: pp.
860–871. 1994
|
|
3
|
Matthay KK, Villablanca JG, Seeger RC,
Stram DO, Harris RE, Ramsay NK, Swift P, Shimada H, Black CT,
Brodeur GM, Gerbing RB and Reynolds CP: Treatment of high-risk
neuroblastoma with intensive chemotherapy, radiotherapy, autologous
bone marrow transplantation and 13-cis-retinoic acid. Children’s
Cancer Group. N Engl J Med. 341:1165–1173. 1999.
|
|
4
|
Roy Choudhury S, Karmakar S, Banik NL and
Ray SK: Targeting angiogenesis for controlling neuroblastoma. J
Oncol. 2012:7820202012. View Article : Google Scholar
|
|
5
|
Ara T, Kusafuka T, Inoue M, Kuroda S,
Fukuzawa M and Okada A: Determination of imbalance between MMP-2
and TIMP-2 in human neuroblastoma by reverse-transcription
polymerase chain reaction and its correlation with tumor
progression. J Pediatr Surg. 35:432–437. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sugiura Y, Shimada H, Seeger RC, Laug WE
and DeClerck YA: Matrix metalloproteinases-2 and-9 are expressed in
human neuroblastoma: contribution of stromal cells to their
production and correlation with metastasis. Cancer Res.
58:2209–2216. 1998.
|
|
7
|
Roomi MW, Roomi N, Ivanov V, Kalinovsky T,
Niedzwiecki A and Rath M: Inhibitory effect of a mixture containing
ascorbic acid, lysine, proline and green tea extract on critical
parameters in angiogenesis. Oncol Rep. 14:807–815. 2005.PubMed/NCBI
|
|
8
|
Roomi MW, Roomi N, Ivanov V, Kalinovsky T,
Niedzwiecki A and Rath M: Inhibition of pulmonary metastasis of
melanoma B16FO cells in C57BL/6 mice by a nutrient mixture
consisting of ascorbic acid, lysine, proline, arginine, and green
tea extract. Exp Lung Res. 32:517–530. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Niedzwiecki A, Roomi MW, Kalinovsky T and
Rath M: Micronutrient synergy - a new tool in effective control of
metastasis and other key mechanisms of cancer. Cancer Metastasis
Rev. 29:529–542. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ribatti D, Marimpietri D, Pastorino F,
Brignole C, Nico B, Vacca A and Ponzoni M: Angiogenesis in
neuroblastoma. Ann NY Acad Sci. 1028:133–142. 2004. View Article : Google Scholar
|
|
11
|
Ribatti D, Vacca A, Nico B, De Falco G,
Montaldo GP and Pnzoni M: Angiogenesis and anti-angiogenesis in
neuroblastoma. Eur J Cancer. 38:750–757. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Rath M and Pauling L: Plasmin-induced
proteolysis and the role of apoprotein(a), lysine and synthetic
analogs. J Orthomolecular Med. 7:17–23. 1992.
|
|
13
|
Sun Z, Chen YH, Wang P, Zhang J, Gurewich
V, Zhang P and Liu JN: The blockage of high-affinity lysine binding
sites of plasminogen by EACA significantly inhibits
prourokinase-induced plasminogen activation. Biochem Biophys Acta.
1596:182–192. 2002.PubMed/NCBI
|
|
14
|
Valcic S, Timmermann BN, Alberts DS,
Wachter GA, Krutzsch M, Wymer J and Guillen JM: Inhibitory effect
of six green tea catechins and caffeine on the growth of four
selected human tumor cell lines. Anticancer Drugs. 7:461–468. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mukhtar H and Ahmad N: Tea polyphenols:
prevention of cancer and optimizing health. Am J Clin Nutr.
71(Suppl 6): S1698–S1704. 2000.PubMed/NCBI
|
|
16
|
Yang GY, Liao J, Kim K, Yurtow EJ and Yang
CS: Inhibition of growth and induction of apoptosis in human cancer
cell lines by tea polyphenols. Carcinogenesis. 19:611–616. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Taniguchi S, Fujiki H, Kobayashi H, Go H,
Miyado K, Sadano H and Shimokawa R: Effect of (−) epigallocatechin
gallate, the main constituent of green tea, on lung metastasis with
mouse B16 melanoma cell lines. Cancer Lett. 65:51–54. 1992.
|
|
18
|
Hara Y: Green Tea: Health Benefits and
Applications. Marcel Dekker, Inc; New York, Basel: 2001, View Article : Google Scholar
|
|
19
|
Kawakami S, Kageyama Y, Fujii Y, Kihara K
and Oshima H: Inhibitory effects of N-acetyl cysteine on invasion
and MMP-9 production of T24 human bladder cancer cells. Anticancer
Res. 21:213–219. 2001.PubMed/NCBI
|
|
20
|
Morini M, Cai T, Aluigi MG, Noonan DM,
Masiello L, De Floro S, D’Agostinin F, Albini A and Fassima G: The
role of the thiol N-acetyl cysteine in the prevention of tumor
invasion and angiogenesis. Int J Biol Markers. 14:268–271.
1999.PubMed/NCBI
|
|
21
|
Yoon SO, Kim MM and Chung AS: Inhibitory
effects of selenite on invasion of HT1080 tumor cells. J Biol Chem.
276:20085–20092. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Carosio R, Zuccari G, Orienti I,
Mangraviti S and Montaldo PG: Sodium ascorbate induces apoptosis in
neuroblastoma cell lines by interfering with iron uptake. Mol
Cancer. 6:552007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Maramag C, Menon M, Balaji KC, Reddy PG
and Laxmanan S: Effect of vitamin C on prostate cancer cells in
vitro: effect on cell number, viability and DNA synthesis.
Prostate. 32:188–195. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Naidu KA, Karl RC, Naidu KA and Coppola D:
Antiproliferative and proapoptotic effect of ascorbyl stearate in
human pancreatic cancer cells: association with decreased
expression of insulin-like growth factor 1 receptor. Dig Dis Sci.
48:230–237. 2003. View Article : Google Scholar
|
|
25
|
Koh WS, Lee SJ, Lee H, Park C, Park MH,
Kim WS, Yoon SS, Park K, Hong SI, Chung MH and Park CH:
Differential effects and transport kinetics of ascorbate
derivatives in leukemic cell lines. Anticancer Res. 18:2487–2493.
1998.PubMed/NCBI
|
|
26
|
Chen Q, Espey MG, Krishna MC, Mitchell JB,
Corpe CP, Buettner GR, Shacter E and Levine M: Pharmacologic
ascorbic acid concentrations selectively kill cancer cells: action
as a pro-drug to deliver hydrogen peroxide to tissues. Proc Natl
Acad Sci USA. 102:13604–13609. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kurbacher CM, Wagner U, Kolster B,
Andreotti PE, Krebs D and Bruckner HW: Ascorbic acid (vitamin C)
improves the antineoplastic activity of doxorubicin, cisplatin and
paclitaxel in human breast carcinoma cells in vitro. Cancer Lett.
103:183–189. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Anthony HM and Schorah CJ: Severe
hypovitaminosis C in lung-cancer patients: the utilization of
vitamin C in surgical repair and lymphocyte-related host
resistance. Br J Cancer. 46:354–367. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Nunez C, Ortiz de Apodaca Y and Ruiz A:
Ascorbic acid in the plasma and blood cells of women with breast
cancer. The effect of consumption of food with an elevated content
of this vitamin. Nutr Hosp. 10:368–372. 1995.(In Spanish).
|
|
30
|
Cooke JP and Dzau VJ: Nitric oxide
synthase: role in the genesis of vascular disease. Annu Rev Med.
48:489–509. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Roomi MW, Ivanov V, Netke SP, Niedzwiecki
A and Rath M: Serum markers of the liver, heart, and kidney and
lipid profile and histopathology in ODS rats treated with nutrient
synergy. J Am Coll Nutr. 22:4772003.
|
